SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?


To: Joe Krupa who wrote (7135)4/16/2001 3:13:50 PM
From: jef saunders  Respond to of 14101
 
what is an nsaid, dmso and dicoflecin (never mentions "pennsaid" nor dimethaid), reviews phase 3 study of 284 people, that 4% had to quit because of skin irritation, does not mention england. says probably not effective for harder to reach joints like back, shoulders, hips. when asked if there would be other topical medications in the wake of this, he said not that he was aware of.